Nanobiotechnology and Nanomedicine Companies

CYTOO focuses on innovative products for the life science research market with an emphasis in cell based assays, high content analysis and cell screening. The company develops, manufactures, and distributes products that make cellular analysis robust and reliable by drastically decreasing cell variability.

Fluxion develops cellular analysis tools in the pharmaceutical, biotech and research industries. The company has developed a proprietary microfluidic platform which enables precise cellular manipulation, rapid low-volume compound addition, environmental control and software-based data acquisition.

Bionanotechnology and microfluidics provide the foundations for GeneFluidics' testing platform. The use of bionanotechnology drives high signal to noise ratios (sensitivity), while the incorporation of microfluidics permits operational simplicity.

Genovis has a broad knowledge within physics, biology and biochemistry and offers nanoparticles as tools in medical imaging and for in vitro/in vivo transfections. We have developed a new category of nanoparticles that generate a contrast effect in more than one type of medical imaging technique and offer customer made nanoparticles which besides the particles per se also include method development and services in the form of pre-studies that are specifically adapted to the individual needs of the customer.

Grapheal makes embedded and wearable biosensors, digital by design, minimalistic in components, with capabilities to dose biomarkers and detect pathogens anywhere with a simple smartphone.

The company's RiboLace micro- and nanoparticle technology is embedded in two products: for better RNA-seq experiments and for better Ribosome Profiling experiments.

A spin off founded to commercialize FDEC FET nano sensor technology invented at Arizona State University.The novel nano sensor technology is capable of exponential capacitive transduction for ultra high sensitivity molecular detection, coupled with exceptional selectivity.

Inanovate creates nano-scale surface structures through a unique and proprietary process capable of nano-meter precision in a time and cost effective way. Leveraging this unique platform and expertise, Inanovate is developing nano-structured biochip substrates to facilitate the next generation in biochip technology.

Develops scientific instrumentation and software for biomolecular and cellular bio applications including submicron analytical devices.

Develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease.

Develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a unique combination of sensitivity, reliability, flexibility and high throughput.

MicroConstants is a GLP-compliant Contract Research Organization (CRO) dedicated to providing premier quality bioanalytical, drug metabolism, pharmacokinetic, formulation and immunoassay support services to pharmaceutical and biotech companies worldwide.

Micronit Microfluidics focuses on developing, prototyping and manufacturing lab-on-a-chip products. Micronit has extensive experience supplying microfluidic solutions to the life sciences industry. Capabilities include nanofluidic channels (depth down to 100 nm).

MMI is a leading company providing scientists with innovative and sophisticated instruments which introduced the use of solid state laser capture microdissection, making this core technology in many scientific fields more efficient and cost effective. The patented adhesive cap is reliable, clean and easy to use. The company's products range from laser microdissection systems and optical tweezers to single cell technologies.

The main focus of our company is the development of precision scientific measuring instrumentation and equipment for research groups at universities and for the pharmaceutical industry, in the field of electrophysiology. MCS products reduce the labor intensive measuring and analyzing processes through miniaturization and automation.

NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.

NanoHybrids develops nanoparticle contrast agents for Photoacoustics, Optical Imaging, Microscopy, Molecular Diagnostic and Theranostic applications.

NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.

Develops and markets cellular imaging systems for the life sciences market.

Manufacturer of nanoparticle immunogold labeling and immunoassay tests.